Link to Full Article Round led by Quark Venture LP and Global Health Sciences (GHS) Fund Funds to support advancement of anti-inflammatory therapy, AuxoraTM, currently being evaluated in severe and critical COVID-19 pneumonia and acute pancreatitis with SIRS Zafi Avnur, Ph.D., chief scientific officer and partner at Quark Venture, joins Board of Director LA JOLLA, […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-11 03:09:562021-03-15 03:11:10CalciMedica Announces $21 Million Series D Financing
Link to Full Article Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Chief Scientific Officer Dr Bill Love Joins UKRI COVID-19 Research and Innovation Taskforce Brighton, United Kingdom – 10th March 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can […]
Link to Full Article VANCOUVER, BC and CARLSBAD, CA – March 8, 2021 – Canary Medical today announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry. “Almost a decade ago, we saw the potential to improve […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-08 03:12:242021-03-15 03:16:31Fierce Medtech Names Canary Medical a “Fierce 15” Company for 2020
Link to Full Article Cambridge, United Kingdom – 1 March 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces the appointment of Kamraan Shariff as Chief Business Development Officer effective immediately. Kamraan will be responsible for developing and implementing the Company’s global business development […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-03-01 03:17:462021-03-15 03:19:00Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Link to Full Article Global Powered Exoskeleton Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 contains an extremely knowledgeable and in-depth evaluation of the present industrial conditions along with market size, estimated from 2020 to 2025. The report encompasses several factors such as global manufacturers, market size, and market factors that affect global […]
Link to Full Article Founder, CEO John Parker Taking on New Role as Chief Scientific Officer, Remaining on Board Artarmon, Australia – February 12, 2021 – Saluda Medical Pty Limited (“Saluda Medical”), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann […]
Link to Full Article MoneyTalks is Stockhead’s regular recap of the ASX stocks and sectors that fund managers and analysts are looking at right now. Today we hear from BioScience Managers’ managing partner Dr Graham Crooke. BioScience Managers is an Australian life sciences investor established in 2003 and has a solid investment record making over 200 investments across […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-02-11 22:54:582021-02-11 22:54:58BIOSCIENCE MANAGERS: This biotech focused fund explains why it invested $15m in these 2 ASX stocks
Link to Full Article Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Brazilian Patent Granted for XF-73 nasal gel preventing post-surgical infections Brighton, United Kingdom – 3rd February 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening […]
Link to Full Article Agreement with Gabriel Precision Oncology to support the routine use of advanced cancer genomics in healthcare Cambridge, United Kingdom – 03 February 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces a collaboration with Gabriel Precision Oncology Limited (“Gabriel”), a spin-out […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2021-02-03 02:03:322021-02-04 02:05:15Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Link to Full Article Acrux (ACR) has wrapped up a share purchase plan that was more than seven times oversubscribed after receiving approximately $15.1 million in applications The placement has since been scaled back to roughly $9.9 million, but still marks a significant increase on the $2 million it was initially seeking ACR says funds […]
CalciMedica Announces $21 Million Series D Financing
/in CalcimedicaLink to Full Article Round led by Quark Venture LP and Global Health Sciences (GHS) Fund Funds to support advancement of anti-inflammatory therapy, AuxoraTM, currently being evaluated in severe and critical COVID-19 pneumonia and acute pancreatitis with SIRS Zafi Avnur, Ph.D., chief scientific officer and partner at Quark Venture, joins Board of Director LA JOLLA, […]
Destiny Pharma CSO Joins UKRI COVID-19 Taskforce
/in Destiny PharmaLink to Full Article Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Chief Scientific Officer Dr Bill Love Joins UKRI COVID-19 Research and Innovation Taskforce Brighton, United Kingdom – 10th March 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can […]
Fierce Medtech Names Canary Medical a “Fierce 15” Company for 2020
/in Canary MedicalLink to Full Article VANCOUVER, BC and CARLSBAD, CA – March 8, 2021 – Canary Medical today announced that it has been named by Fierce Medtech as one of 2020’s Fierce 15, designating it as one of the most promising private companies in the industry. “Almost a decade ago, we saw the potential to improve […]
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
/in CongenicaLink to Full Article Cambridge, United Kingdom – 1 March 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces the appointment of Kamraan Shariff as Chief Business Development Officer effective immediately. Kamraan will be responsible for developing and implementing the Company’s global business development […]
REX BIONICS – Global Powered Exoskeleton Market 2020 Latest Trends
/in Rex BionicsLink to Full Article Global Powered Exoskeleton Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 contains an extremely knowledgeable and in-depth evaluation of the present industrial conditions along with market size, estimated from 2020 to 2025. The report encompasses several factors such as global manufacturers, market size, and market factors that affect global […]
Saluda Medical Announces Executive Leadership Changes
/in Saluda MedicalLink to Full Article Founder, CEO John Parker Taking on New Role as Chief Scientific Officer, Remaining on Board Artarmon, Australia – February 12, 2021 – Saluda Medical Pty Limited (“Saluda Medical”), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the treatment of chronic pain, today announced the appointment of Jim Schuermann […]
BIOSCIENCE MANAGERS: This biotech focused fund explains why it invested $15m in these 2 ASX stocks
/in Acrux, BioSciences Managers, CynataLink to Full Article MoneyTalks is Stockhead’s regular recap of the ASX stocks and sectors that fund managers and analysts are looking at right now. Today we hear from BioScience Managers’ managing partner Dr Graham Crooke. BioScience Managers is an Australian life sciences investor established in 2003 and has a solid investment record making over 200 investments across […]
Destiny Pharma announces Brazilian Patent granted for XF-73 nasal gel
/in Destiny PharmaLink to Full Article Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma Announces Brazilian Patent Granted for XF-73 nasal gel preventing post-surgical infections Brighton, United Kingdom – 3rd February 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening […]
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
/in CongenicaLink to Full Article Agreement with Gabriel Precision Oncology to support the routine use of advanced cancer genomics in healthcare Cambridge, United Kingdom – 03 February 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces a collaboration with Gabriel Precision Oncology Limited (“Gabriel”), a spin-out […]
Acrux (ASX:ACR) receives $15M in applications for $2M SPP
/in AcruxLink to Full Article Acrux (ACR) has wrapped up a share purchase plan that was more than seven times oversubscribed after receiving approximately $15.1 million in applications The placement has since been scaled back to roughly $9.9 million, but still marks a significant increase on the $2 million it was initially seeking ACR says funds […]